Convalescent plasma, an apheresis research project targeting and motivating the fully recovered COVID 19 patients: A rousing message of clinical benefit to both donors and recipients alike
- PMID: 32448638
- PMCID: PMC7177094
- DOI: 10.1016/j.transci.2020.102794
Convalescent plasma, an apheresis research project targeting and motivating the fully recovered COVID 19 patients: A rousing message of clinical benefit to both donors and recipients alike
Keywords: Affinity column prepared immunoglobulins; COVID 19 antibodies; Convalescent plasma derived preparation; Cryoppt-depleted plasma sup; Pathogen inactivation; Plasmapheresis FFP.
Similar articles
-
Treatment for emerging viruses: Convalescent plasma and COVID-19.Transfus Apher Sci. 2020 Jun;59(3):102790. doi: 10.1016/j.transci.2020.102790. Epub 2020 Apr 20. Transfus Apher Sci. 2020. PMID: 32345485 Free PMC article. Review.
-
Plasma from donors convalescent from SARS-CoV-2 infection-A matter of priorities.Transfus Clin Biol. 2020 Aug;27(3):167-168. doi: 10.1016/j.tracli.2020.05.002. Epub 2020 Jun 12. Transfus Clin Biol. 2020. PMID: 32563550 Free PMC article. No abstract available.
-
Feasibility of a pilot program for COVID-19 convalescent plasma collection in Wuhan, China.Transfusion. 2020 Aug;60(8):1773-1777. doi: 10.1111/trf.15921. Epub 2020 Jul 31. Transfusion. 2020. PMID: 32491199 Free PMC article.
-
Challenges in the Production of Convalescent Hyperimmune Plasma in the Age of COVID-19.Semin Thromb Hemost. 2020 Oct;46(7):804-806. doi: 10.1055/s-0040-1713433. Epub 2020 Jun 8. Semin Thromb Hemost. 2020. PMID: 32512588 Free PMC article. No abstract available.
-
Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19.Transfus Apher Sci. 2020 Aug;59(4):102817. doi: 10.1016/j.transci.2020.102817. Epub 2020 May 21. Transfus Apher Sci. 2020. PMID: 32532691 Free PMC article. Review.
Cited by
-
Microfluidic characterisation reveals broad range of SARS-CoV-2 antibody affinity in human plasma.Life Sci Alliance. 2021 Nov 30;5(2):e202101270. doi: 10.26508/lsa.202101270. Print 2022 Feb. Life Sci Alliance. 2021. PMID: 34848436 Free PMC article.
-
Reflection on passive immunotherapy in those who need most: some novel strategic arguments for obtaining safer therapeutic plasma or autologous antibodies from recovered COVID-19 infected patients.Br J Haematol. 2020 Jul;190(1):e27-e29. doi: 10.1111/bjh.16814. Epub 2020 Jun 9. Br J Haematol. 2020. PMID: 32407543 Free PMC article. No abstract available.
-
People with blood disorders can be more vulnerable during COVID-19 pandemic: A hypothesis paper.Transfus Apher Sci. 2021 Jun;60(3):103080. doi: 10.1016/j.transci.2021.103080. Epub 2021 Feb 10. Transfus Apher Sci. 2021. PMID: 33608217 Free PMC article. Review.
-
Convalescent plasma therapy for COVID-19 in patients with nasal catheter oxygen therapy.J Thorac Dis. 2025 Jun 30;17(6):3532-3546. doi: 10.21037/jtd-2024-1991. Epub 2025 Jun 11. J Thorac Dis. 2025. PMID: 40688302 Free PMC article.
-
Convalescent Plasma Therapy for COVID-19: State of the Art.Clin Microbiol Rev. 2020 Aug 12;33(4):e00072-20. doi: 10.1128/CMR.00072-20. Print 2020 Sep 16. Clin Microbiol Rev. 2020. PMID: 32792417 Free PMC article. Review.
References
-
- WHO. Use of convalescent whole blood or plasma collected from patients recovered from Ebola virus disease for transfusion as an empirical treatment during outbreaks 2014. 2020; http://apps.who.int/iris/rest/bitstreams/604045/retrieve (accessed Feb 20, 2020).
-
- Amiral J., Vissac A.M., Seghatchain J. Spotlight: COVID-19, induced activation of haemostais, and immune reactions: can an auto- immune reaction contribute to the delayed severe complications observed in some patients. Transfus Apher Sci. 2020 doi: 10.1016/j.transci.2020.102804. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources